Chase Knickerbocker
Analyst, Craig Hallam
Replay available
DiaMedica Therapeutics Inc. (DMAC) Q3 2025 Earnings Call
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rick Pauls
President and Chief Executive Officer
Matthew Caulfield
Analyst, HC Wainwright
Scott Kellen
Chief Financial Officer
Thomas Flatton
Analyst, Lake Street Capital Markets
Dr. Julie Kropp
Chief Medical Officer
Stacy Koo
Analyst, TD Cowan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Diamedica Therapeutics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.200 Good morning, ladies and gentlemen, and welcome to the Diametica Therapeutics Q3 2025 00:00:06.200 -- 00:00:08.443 earnings conference call. 00:00:08.443 -- 00:00:13.470 An audio recording of this webcast will be available shortly after the call today 00:00:13.470 -- 00:00:17.774 on Diametica's website at www.diametica.com 00:00:19.419 -- 00:00:23.986 in the investor relations section. After our speaker's remarks, there will be a question 00:00:23.986 -- 00:00:27.791 and answer session. If you would like to ask a question during this time, please press 00:00:27.791 -- 00:00:33.284 star 1 on your telephone keypad. Before the company proceeds with its remarks, 00:00:33.284 -- 00:00:37.811 please note that the company will be making forward-looking statements on today's call. 00:00:37.811 -- 00:00:42.878 These statements are subject to risks and uncertainties that could cause 00:00:42.878 -- 00:00:47.846 actual results to differ materially from those projected in these statements. 00:00:47.846 -- 00:00:52.493 More information, including factors that could cause actual results to differ from projected 00:00:52.493 -- 00:00:57.941 results, appear in the section entitled Cautionary Statement Note Regarding Forward-Looking 00:00:57.941 -- 00:01:03.123 Statements in the company's press release issued yesterday and under the heading Risk 00:01:03.123 -- 00:01:08.150 Factors in Diomedica's most recent annual report on Form 10-K and 00:01:08.150 -- 00:01:11.815 most recent quarterly report on Form 10-Q. 00:01:11.815 -- 00:01:15.179 Diomedica's SEC filings 00:01:15.179 -- 00:01:18.501 are available at www.sec.gov 00:01:20.286 -- 00:01:22.349 and on its website. 00:01:22.349 -- 00:01:27.556 Please also note that any comments made on today's cal...